Literature DB >> 32891586

Using the Common Terminology Criteria for Adverse Events (CTCAE - Version 5.0) to Evaluate the Severity of Adverse Events of Anticancer Therapies.

A Freites-Martinez1, N Santana2, S Arias-Santiago3, A Viera4.   

Abstract

Mesh：

Year:  2020        PMID： 32891586     DOI： 10.1016/j.ad.2019.05.009

Source DB:  PubMed          Journal:  Actas Dermosifiliogr (Engl Ed)        ISSN： 2173-5778


× No keyword cloud information.
  62 in total

1.  A durable 4-1BB-based CD19 CAR-T cell for treatment of relapsed or refractory non-Hodgkin lymphoma.

Authors:  Zhitao Ying; Ting He; Shanzhao Jin; Xiaopei Wang; Wen Zheng; Ningjing Lin; Meifeng Tu; Yan Xie; Lingyan Ping; Weiping Liu; Lijuan Deng; Yanping Ding; Xuelian Hu; Bing Bu; Xin'an Lu; Yuqin Song; Jun Zhu
Journal:  Chin J Cancer Res       Date:  2022-02-28       Impact factor: 5.087

2.  Pneumothorax in lung cancer following anlotinib treatment: A case report.

Authors:  Lei Yang
Journal:  Medicine (Baltimore)       Date:  2022-07-22       Impact factor: 1.817

3.  COMbined Exercise Trial (COMET) to improve cognition in older adults: Rationale and methods.

Authors:  Amanda Szabo-Reed; Jonathan Clutton; Sydney White; Angela Van Sciver; Dreu White; Jill Morris; Laura Martin; Rebecca Lepping; Ashley Shaw; Jaime Perales Puchalt; Robert Montgomery; Jonathan Mahnken; Richard Washburn; Jeffrey Burns; Eric D Vidoni
Journal:  Contemp Clin Trials       Date:  2022-05-27       Impact factor: 2.261

4.  Short-term outcomes of neoadjuvant sintilimab with chemotherapy in stage III non-small cell lung cancer: a case series.

Authors:  Bo-Shi Fan; Xing-Tong Wang; Shou-Yin Di; Jia-Hua Zhao; Si-Yu Chen; Shao-Hua Zhou; Cai-Ying Yue; Wei-An Song; Tai-Qian Gong
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

5.  Long-Term Efficacy and Safety of Anlotinib as a Monotherapy and Combined Therapy for Advanced Sarcoma.

Authors:  Weitao Yao; Xinhui Du; Jiaqiang Wang; Xin Wang; Peng Zhang; Xiaohui Niu
Journal:  Onco Targets Ther       Date:  2022-06-14       Impact factor: 4.345

6.  Risk factors for oral mucositis during chemotherapy treatment for solid tumors: a retrospective STROBE-guided study.

Authors:  J-O Martins; M-M Borges; C-E Malta; A-C Carlos; A-A Crispim; J-F Moura; I-J Fernandes-Lima; P-G Silva
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-07-01

7.  Percutaneous CT-Guided Microwave Ablation Combined with Vertebral Augmentation for Treatment of Painful Spinal Metastases.

Authors:  L Chen; G Hou; K Zhang; Z Li; S Yang; Y Qiu; Q Yuan; D Hou; X Ye
Journal:  AJNR Am J Neuroradiol       Date:  2022-02-03       Impact factor: 3.825

8.  The Efficacy and Safety of Carbon Ion Radiotherapy for Meningiomas: A Systematic Review and Meta-Analysis.

Authors:  Jie-Yun Li; Jing-Wen Li; Yuan-Chang Jin; Mei-Xuan Li; Li-Ping Guo; Zhi-Tong Bing; Qiu-Ning Zhang; Fei Bai; Xiao-Hu Wang; Xiu-Xia Li; Ke-Hu Yang
Journal:  Front Oncol       Date:  2021-05-25       Impact factor: 6.244

9.  Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial.

Authors:  Ivan Delgado-Enciso; Juan Paz-Garcia; Carlos E Barajas-Saucedo; Karen A Mokay-Ramírez; Carmen Meza-Robles; Rodrigo Lopez-Flores; Marina Delgado-Machuca; Efren Murillo-Zamora; Jose A Toscano-Velazquez; Josuel Delgado-Enciso; Valery Melnikov; Mireya Walle-Guillen; Hector R Galvan-Salazar; Osiris G Delgado-Enciso; Ariana Cabrera-Licona; Eduardo J Danielewicz-Mata; Pablo J Mandujano-Diaz; José Guzman-Esquivel; Daniel A Montes-Galindo; Henry Perez-Martinez; Jesus M Jimenez-Villegaz; Alejandra E Hernandez-Rangel; Patricia Montes-Diaz; Iram P Rodriguez-Sanchez; Margarita L Martinez-Fierro; Idalia Garza-Veloz; Daniel Tiburcio-Jimenez; Sergio A Zaizar-Fregoso; Fidadelfo Gonzalez-Alcaraz; Laydi Gutierrez-Gutierrez; Luciano Diaz-Lopez; Mario Ramirez-Flores; Hannah P Guzman-Solorzano; Gustavo Gaytan-Sandoval; Carlos R Martinez-Perez; Francisco Espinoza-Gómez; Fabián Rojas-Larios; Michael J Hirsch-Meillon; Luz M Baltazar-Rodriguez; Enrique Barrios-Navarro; Vladimir Oviedo-Rodriguez; Martha A Mendoza-Hernandez; Emilio Prieto-Diaz-Chavez; Brenda A Paz-Michel
Journal:  Exp Ther Med       Date:  2021-06-29       Impact factor: 2.447

10.  Stereotactic body radiation therapy (SBRT) of adrenal gland metastases in oligometastatic and oligoprogressive disease.

Authors:  Leonid B Reshko; Jeremy T Gaskins; Craig L Silverman; Neal E Dunlap
Journal:  Rep Pract Oncol Radiother       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.